We are live on ! Find out more
JAMONY

Jacob Asset Management of New York Portfolio holdings

AUM $70.9M
1-Year Est. Return 14.28%
This Fund
S&P 500
This Quarter Est. Return
-13.7%
1 Year Est. Return
+14.28%
3 Year Est. Return
+22.72%
5 Year Est. Return
10 Year Est. Return
AUM
$70.9M
AUM Growth
-$17.8M
Cap. Flow
-$3.27M
Cap. Flow %
-4.61%
Top 10 Hldgs %
41.06%
Holding
68
New
2
Increased
23
Reduced
33
Closed
2

Top Sells

Rank Stock Value
1
ROVR
Rover Group, Inc. Class A Common Stock
ROVR
+$1.52M
2
EDU icon
New Oriental
EDU
+$1.13M
3
Z icon
Zillow
Z
+$1.07M
4
LTRX icon
Lantronix
LTRX
+$797K
5
BRZE icon
Braze
BRZE
+$739K

Sector Composition

Rank Sector Weight
1 Technology 42.81%
2 Healthcare 19.95%
3 Communication Services 13.35%
4 Consumer Discretionary 13.07%
5 Industrials 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOYU
51
DouYu International Holdings
DOYU
$140M
$339K 0.48%
34,800
+2,300
+7% +$24.1K
HRTX icon
52
Heron Therapeutics
HRTX
$94.5M
$337K 0.48%
327,450
+50,435
+18% +$71.8K
IZEA icon
53
IZEA Worldwide
IZEA
$60.4M
$248K 0.35%
114,650
+10,000
+10% +$23K
CDXS icon
54
Codexis
CDXS
$159M
$248K 0.35%
131,021
-67,450
-34% -$158K
ARCT icon
55
Arcturus Therapeutics
ARCT
$173M
$196K 0.28%
7,677
-2,400
-24% -$73.9K
APLS
56
DELISTED
Apellis Pharmaceuticals
APLS
$184K 0.26%
4,850
+4,416
+1,018% +$194K
CRSP icon
57
CRISPR Therapeutics
CRSP
$4.99B
$182K 0.26%
4,003
+390
+11% +$20.1K
SDGR icon
58
Schrodinger
SDGR
$1.33B
$173K 0.24%
6,115
-781
-11% -$31.5K
OMER icon
59
Omeros
OMER
$951M
$161K 0.23%
55,168
-25,000
-31% -$100K
DTIL icon
60
Precision BioSciences
DTIL
$191M
$133K 0.19%
13,014
BEAM icon
61
Beam Therapeutics
BEAM
$2.81B
$116K 0.16%
4,829
+435
+10% +$11.7K
SCYX icon
62
SCYNEXIS
SCYX
$51.8M
$114K 0.16%
6,250
ESPR
63
DELISTED
Esperion Therapeutics
ESPR
$58.8K 0.08%
+60,000
New +$86.8K
LEJU
64
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$52.9K 0.07%
33,903
-21,474
-39% -$44.4K
AEO icon
65
American Eagle Outfitters
AEO
$2.97B
$47.7K 0.07%
2,869
-8,700
-75% -$129K
NBSE
66
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$13.6K 0.02%
15,655
EDU icon
67
New Oriental
EDU
$9.04B
-28,528
Closed -$1.13M
DMTK
68
DELISTED
DermTech, Inc. Common Stock
DMTK
-42,825
Closed -$111K

Similar funds

Jacob Asset Management of New York's Q3 2023 Portfolio in Review

As of Q3 2023, Jacob Asset Management of New York held 68 positions worth $70.9M, down 20% from $88.7M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Jacob Asset Management of New York withdrew a net $3.27M in Q3 2023, closing 2 positions and reducing 33 holdings. Its most notable exit was New Oriental, an estimated $1.13M position sold in full.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Jacob Asset Management of New York opened a new position in SoFi Technologies worth $388K.

  • Jacob Asset Management of New York's largest Q3 2023 buy was SoFi Technologies: 48,600 shares worth $388K.
  • Jacob Asset Management of New York added most to Confluent in Q3 2023, an estimated $1.12M increase.
  • Jacob Asset Management of New York's biggest Q3 2023 reduction was Rover Group, Inc. Class A Common Stock, cutting an estimated $1.52M.
  • Jacob Asset Management of New York fully exited New Oriental in Q3 2023, selling an estimated $1.13M.
  • Jacob Asset Management of New York's ten largest holdings make up 41% of its $70.9M portfolio in Q3 2023.
  • Jacob Asset Management of New York opened 2 new positions and closed 2 in Q3 2023.
  • Jacob Asset Management of New York's portfolio value fell 20% quarter-over-quarter to $70.9M.

Based on Jacob Asset Management of New York's 13F filing for Q3 2023, filed 1 Nov 2023.